Literature DB >> 24972347

Microhemorrhage is an early event in the pulmonary fibrotic disease of PECAM-1 deficient FVB/n mice.

Marta Lishnevsky1, Lena C Young2, Steven J Woods2, Steven D Groshong3, Randall J Basaraba2, John M Gilchrist4, David M Higgins5, Mercedes Gonzalez-Juarrero2, Todd A Bass6, William A Muller7, Alan R Schenkel2.   

Abstract

Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1) deficient mice in the FVB/n strain exhibit fatal chronic pulmonary fibrotic disease. The illness occurs in the absence of a detectable pro-inflammatory event. PECAM-1 is vital to the stability of vascular permeability, leukocyte extravasation, clotting of platelets, and clearance of apoptotic cells. We show here that the spontaneous development of fibrotic disease in PECAM-1 deficient FVB/n mice is characterized by early loss of vascular integrity in pulmonary capillaries, resulting in spontaneous microbleeds. Hemosiderin-positive macrophages were found in interstitial spaces and bronchoalveolar lavage (BAL) fluid in relatively healthy animals. We also observed a gradually increasing presence of hemosiderin-positive macrophages and fibrin deposition in the advanced stages of disease, corresponding to the accumulation of collagen, IL-10 expression, and myofibroblasts expressing alpha smooth muscle actin (SMA). Together with the growing evidence that pulmonary microbleeds and coagulation play an active part in human pulmonary fibrosis, this data further supports our hypothesis that PECAM-1 expression is necessary for vascular barrier function control and regulation of homeostasis specifically, in the pulmonary environment.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Interstitial fibrosis; Macrophage biology; Pulmonary oedema

Mesh:

Substances:

Year:  2014        PMID: 24972347      PMCID: PMC4414406          DOI: 10.1016/j.yexmp.2014.06.008

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  26 in total

1.  Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies.

Authors:  Cynthia M Magro; W James Waldman; Deborah A Knight; James N Allen; Tibor Nadasdy; Gwyn E Frambach; Patrick Ross; Clay B Marsh
Journal:  Hum Immunol       Date:  2006-04-05       Impact factor: 2.850

Review 2.  PECAM-1: conflicts of interest in inflammation.

Authors:  Jamie R Privratsky; Debra K Newman; Peter J Newman
Journal:  Life Sci       Date:  2010-06-10       Impact factor: 5.037

3.  Different susceptibilities of PECAM-deficient mouse strains to spontaneous idiopathic pneumonitis.

Authors:  Alan R Schenkel; Tina W Chew; Elizabeth Chlipala; Marcus W N Harbord; William A Muller
Journal:  Exp Mol Pathol       Date:  2006-02-02       Impact factor: 3.362

Review 4.  Alternative activation of macrophages: mechanism and functions.

Authors:  Siamon Gordon; Fernando O Martinez
Journal:  Immunity       Date:  2010-05-28       Impact factor: 31.745

Review 5.  Murine models of pulmonary fibrosis.

Authors:  Bethany B Moore; Cory M Hogaboam
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-09       Impact factor: 5.464

Review 6.  Role of coagulation and fibrinolysis in lung and renal fibrosis.

Authors:  C Ruppert; P Markart; M Wygrecka; K T Preissner; A Günther
Journal:  Hamostaseologie       Date:  2008-02       Impact factor: 1.778

7.  Non-invasive diagnosis of early pulmonary disease in PECAM-deficient mice using infrared pulse oximetry.

Authors:  Merideth A Early; Marta Lishnevsky; John M Gilchrist; David M Higgins; Ian M Orme; William A Muller; Mercedes Gonzalez-Juarerro; Alan R Schenkel
Journal:  Exp Mol Pathol       Date:  2009-07-28       Impact factor: 3.362

Review 8.  Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?

Authors:  R C Chambers
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

Review 9.  Exploring the full spectrum of macrophage activation.

Authors:  David M Mosser; Justin P Edwards
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

10.  Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF).

Authors:  Kathy Boon; Nathaniel W Bailey; Jun Yang; Mark P Steel; Steve Groshong; Dolly Kervitsky; Kevin K Brown; Marvin I Schwarz; David A Schwartz
Journal:  PLoS One       Date:  2009-04-06       Impact factor: 3.240

View more
  5 in total

1.  Pathogenesis of Diffuse Alveolar Hemorrhage in Murine Lupus.

Authors:  Haoyang Zhuang; Shuhong Han; Pui Y Lee; Ravil Khaybullin; Stepan Shumyak; Li Lu; Amina Chatha; Anan Afaneh; Yuan Zhang; Chao Xie; Dina Nacionales; Lyle Moldawer; Xin Qi; Li-Jun Yang; Westley H Reeves
Journal:  Arthritis Rheumatol       Date:  2017-05-05       Impact factor: 10.995

2.  Control of vascular permeability by adhesion molecules.

Authors:  Ingrid H Sarelius; Angela J Glading
Journal:  Tissue Barriers       Date:  2015-04-03

3.  Generation of PECAM-1 (CD31) conditional knockout mice.

Authors:  Huiying Zhi; Taisuke Kanaji; Guoping Fu; Debra K Newman; Peter J Newman
Journal:  Genesis       Date:  2019-11-15       Impact factor: 2.487

4.  Differential effect of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) on leukocyte infiltration during contact hypersensitivity responses.

Authors:  Merideth Early; William G Schroeder; Ranajana Unnithan; John M Gilchrist; William A Muller; Alan Schenkel
Journal:  PeerJ       Date:  2017-07-10       Impact factor: 2.984

5.  CD31+, CD38+, CD44+, and CD103+ lymphocytes in peripheral blood, bronchoalveolar lavage fluid and lung biopsy tissue in sarcoid patients and controls.

Authors:  Regina Aleksonienė; Justinas Besusparis; Vygantas Gruslys; Laimutė Jurgauskienė; Aida Laurinavičienė; Arvydas Laurinavičius; Radvilė Malickaitė; Jolita Norkūnienė; Rolandas Zablockis; Edvardas Žurauskas; Edvardas Danila
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.